Supplemental oxygen users with pulmonary fibrosis perceive greater dyspnea than oxygen non-users

BACKGROUND: Exertional dyspnea is a hallmark symptom of fibrosing interstitial lung disease (fILD), and oxygen (O(2)) desaturation is common among patients with fILD. Supplemental O(2) is prescribed to maintain normoxia and alleviate dyspnea. We sought to better understand the associations between O...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Mengshu, Wamboldt, Frederick S., Brown, Kevin K., Hickman, Jonathon, Olson, Amy L., Solomon, Joshua J., Swigris, Jeffrey J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676151/
https://www.ncbi.nlm.nih.gov/pubmed/26693009
http://dx.doi.org/10.1186/s40248-015-0035-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676151/
https://www.ncbi.nlm.nih.gov/pubmed/26693009
http://dx.doi.org/10.1186/s40248-015-0035-y

Ejemplares similares